Moreover, recent studies indicating the place of COX-2 inhibitors in the prevention of several cancer types such as colon, breast, lung and prostate cancers [7–10] and neurodegenerative diseases such as Parkinson [11] and Alzheimer’s [12] diseases still continues to attract investigations on development of COX-2 inhibitors. This evidence concerns the gene PTGS2 and Parkinson disease.